Effects of Clinical Interventions for the Management of Late Start
- Disease/Condition
- Athletes
- Drug/Device/Intervention
- massage
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- São Paulo State University
- Location
- Rio de Janeiro, Brazil
- Phase
- N/A
- Start date
- Nov 20, 2020
- End date
- Mar 20, 2021
- Enrollment
- 50 participants
PAIN,SATISFACTION
Introduction: Late-onset muscle pain (DOMS) is characterized by a type of temporary muscle
 damage, common after high-intensity exercise. In addition to pain, DOMS clinically generates
 muscle stiffness, reduced joint range of motion, muscle weakness and reduced peak torque. In
 this regard, in order to accelerate the recovery of body systems and treat symptoms of DOMS,
 the management of different types of interventions has been observed, supporting the clinical
 practice, based on evidence. Objectives: To investigate the effect of different types of
 clinical interventions for the treatment of DOMS. Material and methods: For the clinical
 trial, 50 ultramarathon and rowing athletes of both sexes, aged between 18 and 60 years old,
 will be recruited randomly into four possible groups: control (CG), shock waves (G1) ,
 massage (G2) and laser therapy (G3). The evaluation moments will be as follows: minutes
 before exercise (M1); immediately after exercise (M2); immediately after applying the
 recovery technique (M3); and 24 hours after exercise (M4) and the evaluated outcomes will be:
 pain, psychological aspects, functional test and blood markers.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04628403
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04628403 through Pure Global AI's free database. This phase not specified trial is sponsored by São Paulo State University and is currently Not yet recruiting. The study focuses on Athletes. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.